Honghao Zhou

Determination of two HMG‐CoA reductase inhibitors, pravastatin and pitavastatin, in plasma samples using liquid chromatography–tandem mass spectrometry for pharmaceutical study

Jian‐Wei Deng, Kwon‐Bok Kim, Im‐Sook Song et al. · Biomedical Chromatography · 2007 · 38 citations

Preoperative circulating tumor cells to predict microvascular invasion and dynamical detection indicate the prognosis of hepatocellular carcinoma

Jiangmin Zhou, Zhiwei Zhang, Honghao Zhou et al. · BMC Cancer · 2020 · 38 citations · Full text

Pharmacokinetic Comparisons of Albiflorin and Paeoniflorin after Oral Administration of Shaoyao-Gancao-Tang and Single Herb Paeony Decoction to Rats

Pingping Gan, Zhong Mei-zuo, Xi Huang et al. · Planta Medica · 2011 · 35 citations

Molecular Pharmacology, Medicinal Chemistry, Pharmacological Study +15

Regulation of ERK and AKT pathways by hepatitis B virus X protein via the Notch1 pathway in hepatocellular carcinoma

Bo Liao, Honghao Zhou, Huifang Liang et al. · International Journal of Oncology · 2017 · 34 citations · Full text

Immunology, Pathology, Hcc Carcinogenesis +17

MicroRNA-184 acts as a potential diagnostic and prognostic marker in epithelial ovarian cancer and regulates cell proliferation, apoptosis and inflammation.

Chong-Zhen Qin, Xiao-Ya Lou, Qiao‐Li Lv et al. · PubMed · 2015 · 29 citations

Epithelial Ovarian Cancer, Pathology, Cell Proliferation +16